NCT07096791

A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of KH607 in the Treatment of Adult Female Participants With Postpartum Depressive Disorder

• Status: Not Yet Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 72 (estimated)
• Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd. · Industry
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

This is a study evaluating the efficacy, and safety of KH607 in 72 participants diagnosed with Postpartum Depressive Disorder.

Detailed description

The study is a randomized, double-blind, parallel-group, placebo-controlled design. Eligible participants were randomized to KH607 group or placebo group for 14 days.

Conditions

• Postpartum Depressive Disorder

Interventions

Type	Name	Description
DRUG	KH607 tablet	oral，once daily for 14 days
DRUG	placebo	oral，once daily for 14 days

Timeline

• Start date: 2025-07-01
• Primary completion: 2027-01-01
• Completion: 2027-04-01
• First posted: 2025-07-31
• Last updated: 2025-07-31